PODCAST

CME

ReachMD

science & medicine medicine

All Episodes

00:05:30

The Clinical Spectrum of Hepatic Encephalopathy

CME ·

2025/10/23

Faculty: Robert Brown Jr, MD, MPH Faculty: Steven Flamm, MD This series of brief episodes addresses how primary care providers can recognize early and often subtle signs of hepatic encephalopathy to support timely diagnosis and intervention. Drs. Robert Brown and Steven Flamm discuss clinical indicators that may prompt treatment initiation or specialist referral. The discussion focuses on optimizing patient care through early recognition and appropriate management strategies in the

00:04:30

Hepatic Encephalopathy: An Ominous Sign

CME ·

2025/10/23

00:04:00

Hepatic Encephalopathy: Tipping the Balance

CME ·

2025/10/23

00:05:15

You Can’t Diagnose MHE Unless You Diagnose Cirrhosis

CME ·

2025/10/23

00:05:30

Treatment of Overt Hepatic Encephalopathy

CME ·

2025/10/23

00:04:45

Diagnosing Minimal Hepatic Encephalopathy: There's an...

CME ·

2025/10/23

00:05:15

Hepatic Encephalopathy: Unmet Therapeutic Needs

CME ·

2025/10/23

00:05:15

Advances in the Treatment of Hepatic Encephalopathy

CME ·

2025/10/23

00:04:00

Hepatic Encephalopathy: What's Sarcopenia Got to Do...

CME ·

2025/10/23

00:57:00

ENDOVOICE Live: Endometriosis—A Chronic Burden of...

CME ·

2025/10/22

Faculty: Linda Bradley, MD Faculty: Obianuju Sandra Madueke-Laveaux, MD, MPH Faculty: Lauren R. Kornegay This dynamic symposium will guide clinicians through a modern, patient-centered approach to endometriosis care. Faculty will explore how early diagnosis can improve physical and psychosocial outcomes, examine tools to advance equity and shared decision-making, and evaluate the latest evidence for GnRH antagonists as a nonsurgical treatment strategy. The session concludes

00:28:30

Optimizing Outcomes in Patients With oHCM: The...

CME ·

2025/10/21

Faculty: Iacopo Olivotto, MD Faculty: Ahmad Masri, MD, MS Faculty: Pablo Garcia-Pavia, MD, PhD Faculty: Fabian Knebel, MD, PhD Faculty: Caroline Coats, MD Hypertrophic cardiomyopathy (HCM) management is being transformed by advances in diagnostics and the emergence of targeted therapies. In this program, leading international experts review challenges in early recognition, the evolving role of beta-blockers and traditional therapies, and the clinical impact of novel

01:01:30

Diagnosing and Treating IBS: It Begins With One...

CME ·

2025/10/20

Faculty: Brooks D. Cash, MD, AGAF, FACG, FACP, FASGE Faculty: Kimberly D. Orleck, PA-C Presented at the 21st Annual Women’s Health Annual Visit (WHAV 2025), this session reviews strategies for diagnosing and treating irritable bowel syndrome (IBS), with a focus on distinguishing IBS-C from IBS-D. Faculty explore the burden of disease, stigma, and the importance of a positive diagnostic strategy using Rome IV criteria, supported by history, physical examination, and selective

00:00:00

Treatment Revolution in IgA Nephropathy

CME ·

2025/09/24

Faculty: Shikha Wadhwani, MD Faculty: Dana Rizk, MD For the second episode of the KDIGO IgA Nephropathy (IgAN) podcast series, Dr. Dana Rizk and Dr. Shikha Wadhwani discuss the IgAN treatment revolution. The conversation explores how a deeper understanding of the disease's pathophysiology has led to new therapeutic options, moving beyond traditional supportive care. Key topics include: The shift in IgAN treatment since the KDIGO 2021 guidelines a The four-hit hypothesis of

00:00:00

Collaborative Care for CRSwNP Expert and Patient...

CME ·

2025/09/12

Host: Stella Lee, MD Guest: Katie Buchheit, MD Guest: Michael E. Wechsler, MD, MMSc Chronic rhinosinusitis with nasal polyps (CRSwNP) presents a large burden on more than 3 million patients with the conditions — especially when intertwined with asthma and allergy. Join our discussion between patients with CRSwNP and leading experts in ENT, allergy, and pulmonary medicine as they: Breakdown how to recognize key inflammatory patterns. Discuss the burden of illness and goals of

00:00:00

Global Perspectives on Perioperative Immunotherapy in...

CME ·

2025/08/29

Host: Kevin J Harrington, PhD, FRCP, FRCR, FRSB Host: Christophe Le Tourneau, MD, PhD Join our experts as they examine the integration of perioperative immune checkpoint inhibitors (ICIs) in the management of resectable locally advanced head and neck squamous cell carcinoma (LA HNSCC). Drs. Le Tourneau and Harrington discuss unmet needs and limitations of current treatment and review data from trials supporting the use of perioperative ICIs, emphasizing their event-free survival

00:00:00

Chairperson Perspective: Acromegaly Care:...

CME ·

2025/08/15

Host: Maria Fleseriu, MD, FACE Acromegaly, a rare endocrine disorder caused by excessive growth hormone (GH) secretion, has a profound impact on affected individuals and healthcare systems. Patients often experience delays in diagnosis, averaging 4 to 6 years, which exacerbates disease progression and leads to irreversible comorbidities. Do you know how to effectively treat acromegaly to increase your patients’ quality of life? Tune in for an overview of the latest data.

00:00:00

Advanced Therapeutic Strategies and Resistance...

CME ·

2025/08/14

Host: Shankara Paneesha, MD FRCP FRCPath Listen to Dr. Shankara Paneesha and discover the evolving treatment landscape for relapsed CLL. Get insights on BTK resistance, new treatment options including cellular therapy, and the importance of patient-specific factors in treatment decisions.

00:00:00

Breaking New Ground: Acoramidis Reduces AF Events in...

CME ·

2025/08/08

Faculty: Kevin Alexander, MD This brief clinical discussion examines findings presented at the ESC Heart Failure 2025 meeting in Belgrade, Serbia, on the impact of acoramidis in transthyretin amyloid cardiomyopathy (ATTR-CM). The analysis highlights a reduction in atrial fibrillation events and an improvement in cardiovascular outcomes among patients treated with acoramidis, including those with both wild-type and variant transthyretin (TTR). Data from the ATTRibute-CM study are

00:00:00

Community Clinic: Translating Data Into Action ─...

CME ·

2025/07/25

Guest: Robert J. Motzer, MD Guest: Elizabeth R. Plimack, MD, MS, FASCO Our experts, Drs. Robert Motzer and Elizabeth Plimack, discuss first-line treatment strategies for advanced renal cell carcinoma in a community clinic setting. Drawing from pivotal clinical trials and guideline recommendations, they highlight how to personalize therapy based on IMDC risk stratification and patient characteristics. Practical decision-making in both intermediate- and poor-risk disease is examined

00:00:00

TTR Levels and Associated Disease Risk: Insights from...

CME ·

2025/07/24

Faculty: Ahmad Masri, MD, MS Review findings from the UK Biobank presented recently at the Peripheral Nerve Society meeting, revealing that naturally low transthyretin (TTR) levels are associated with a higher prevalence of cardiovascular biomarkers, such as NT-proBNP, and comorbidities, including peripheral arterial disease, stroke, and cognitive decline. The data suggest that low TTR may serve as a marker of broader systemic illness, both in patients with TTR amyloidosis and in the

330 results

CME

All Episodes

Similar Podcasts

科学史评话最新专辑

科学史评话

Hablando con Científicos - Cienciaes.com

cienciaes.com

天方烨谈

基因频道

The Permaculture Podcast

Scott Mann

汪诘：科学有故事（主打）

科学有故事